SGO 2022 Conference Coverage on VuMedi


 

SGO 2022 Update on Maintenance Olaparib Rechallenge in Patients With Ovarian Carcinoma: Results From the OReO/ENGOT Ov-38 Trial

74 views
March 24, 2022
Comments 0
Login to view comments. Click here to Login